4-(DIFLUOROMETHOXY)PIPERIDINE HCL, 95.0%, 1g

tert-Butyl (R)-3-(4-bromo-1H-pyrazol-1-yl)pyrrolidine-1-carboxylate, 95%, 100mg

N-Boc-4,5,6,7-Tetrahydro-thieno[2,3-c]pyridine-3-carboxylic acid ethyl ester, 97.0%, 250mg

N,N-Diéthylaniline , >=98.5%, pour la synthèse, 250 ml, emballage en verre

1-Fluoro-3-isobutoxy-2-nitrobenzene, 95.0%, 1g

(R)-3-(P-FLUOROPHENYL)-BETA-ALANINE, 97%, 100mg

1-(1-methyl-1H-pyrazol-3-yl)ethanone, 95.0%, 1g

N-(1-((2R,3R,4R,5R)-5-((bis(4-Methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-(2-methoxyethoxy)tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)benzamide, 97%, 250mg

(-)-Ambroxide>98.0%(GC)25g

2,3-Dihydro-1H-isoindol-4-amine, 95+%, 100mg

3-Bromo-2,6-difluorobenzonitrile, 97%, 1g

[1-(2-Chlorobenzyl)cyclopropyl]amine hydrochloride, 1g

3-Chlorobenzoic acid, 95.0%, 100g